Taylor Holly A
Department of Health Policy and Management, Bloomberg School of Public Health, Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD 21205, USA.
Clin Trials. 2008;5(2):140-6. doi: 10.1177/1740774508089457.
Current National Institutes of Health (NIH) policy mandates the inclusion of women, minorities and children in clinical research. Institutional Review Boards (IRB), NIH Scientific Review Groups (SRG) and NIH program staff all have responsibility for the evaluation of Principal Investigator (PI) adherence to the inclusion guidelines.
The purpose of this survey was to describe the experience with and attitudes of SRG members toward the inclusion guidelines and to identify characteristics of respondents that predict their attitudes towards the policy.
A survey was sent to 746 SRG members. 425 SRG members responded and univariate and bivariate statistical analysis conducted.
The results of the survey identify one clear measure of success regarding the implementation of the NIH guidelines; SRG members indicate the guidelines are in part responsible for their attention to the inclusion of women, minorities and children in clinical research. In addition, SRG members believe that gender and race are important factors when assessing the diversity of study samples and that the current NIH guidelines are adequate for encouraging their inclusion. As a proxy measure of success, SRG members believe that PIs responsible for protocols reviewed by their study group are generally compliant with the inclusion guidelines.
At least one potential limitation of this study is that while an effort was made to assure confidentiality, because the project was funded by the NIH, respondents may have been less critical of the guidelines than they would have been if the study was funded by non-NIH funds.
Future research ought to explore whether IRB members and NIH program officers find PIs to be compliant as their projects get underway. In addition, more research ought to be conducted to assess the downstream effects of this important social policy.
美国国立卫生研究院(NIH)现行政策要求在临床研究中纳入女性、少数族裔和儿童。机构审查委员会(IRB)、NIH科学审查小组(SRG)和NIH项目工作人员都有责任评估首席研究员(PI)对纳入指南的遵守情况。
本次调查的目的是描述SRG成员对纳入指南的经验和态度,并确定能够预测他们对该政策态度的受访者特征。
向746名SRG成员发送了调查问卷。425名SRG成员进行了回复,并进行了单变量和双变量统计分析。
调查结果确定了一项关于NIH指南实施成功的明确衡量标准;SRG成员表示,这些指南在一定程度上促使他们关注在临床研究中纳入女性、少数族裔和儿童。此外,SRG成员认为,在评估研究样本的多样性时,性别和种族是重要因素,并且当前的NIH指南足以鼓励纳入这些人群。作为成功的一项替代衡量标准,SRG成员认为,负责其研究小组审查方案的PI总体上遵守纳入指南。
本研究至少有一个潜在局限性,即尽管努力确保了保密性,但由于该项目由NIH资助,受访者对这些指南的批评可能不如研究由非NIH资金资助时那么严厉。
未来的研究应该探讨IRB成员和NIH项目官员是否会在PI的项目开展过程中发现他们是合规的。此外,应该进行更多研究来评估这项重要社会政策的下游影响。